USPTO serial 79019327
DIOSYNTH BIOTECHNOLOGY
Reviewed by CopyMark Law Group
Reg. 3307447Status 404
- Filing date
- Status date
- Registration date
- Oct 9, 2007
- Examiner
- POWERS, ALEXANDER L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DIOSYNTH BIOTECHNOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NL
NL
NL
NL
NL
NL
JP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations and substances for manufacturing of pharmaceutical products, including chemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines; chemicals for manufacturing cosmetics, skin cleansers and medicines; chemical preservatives for pharmaceutical preparations; biochemicals, namely polypeptides, recombinant proteins, organic peptide substrates and monoclonal antibodies for producing products for genetic pharmacology | SECTION 71 - CANCELLED | — |
| 005 | medicines and pharmaceutical products, including medicines and pharmaceutical products for veterinary use, namely medicines and pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital disorders and, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfuntion, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; pharmaceutical preparations, namely preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations, contraceptives, muscle relaxants, muscle relaxant antagonists; biotechnological preparations for medical use; biochemicals, namely biochemical preparations for medical use; genetic material, namely tissue, for genetic cell therapy | SECTION 71 - CANCELLED | — |
| 009 | Downloadable electronic publications, namely, books, magazines, and manuals on the production of biotechnology, pharmaceutical, and veterinary products | SECTION 71 - CANCELLED | — |
| 016 | informative books, magazines, manuals in printed form on the production of products for biotechnology and of pharmaceutical and veterinary preparations and products | SECTION 71 - CANCELLED | — |
| 040 | contract manufacturing in the medical and pharmaceutical fields, namely preparing medicines and pharmaceutical products with the aid of biotechnology | SECTION 71 - CANCELLED | — |
| 042 | services of biotechnical, chemical and pharmacological laboratories, namely scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; providing expert pharmaceutical advice on the subject of scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific research, namely, carrying out early evaluations in the field of new medicines; development of pharmaceutical preparations, medicines and medicaments; technological services, namely technological consultation and research in the pharmaceutical and health care industries; scientific analysis and research, namely evaluation of pharmaceutical products; research and development in the pharmaceutical field; scientific research and development with regard to medicines; product development, namely preparation of pharmaceutical test products; pharmaceutical consultation, namely advice regarding scientific research, development and analyses of medicines; pharmaceutical consultation, namely advice regarding scientific research and analyses relating to medicines; development of new technologies in the biotechnology sector; providing information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector; licensing of intellectual property, namely granting licenses in the fields of genetic pharmacology and biotechnology | SECTION 71 - CANCELLED | — |
| 044 | Medical examination of patients | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MERCK SHARP & DOHME B.V.
- Other trademarks owned by MSD Oss B.V.
- Other trademarks owned by N.V. Organon
- Other trademarks owned by Diosynth B.V.
- Other trademarks owned by Diosynth B.V.
- Other trademarks owned by Diosynth B.V.
- Other trademarks owned by FUJIFILM Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DIOSYNTH BIOTECHNOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 12, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 3, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 11, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 11, 2015 | INPC | INVALIDATION PROCESSED | — |
| Mar 19, 2015 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 16, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 16, 2014 | C71T | CANCELLED SECTION 71 | — |
| Nov 9, 2013 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 22, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 2, 2012 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 15, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 5, 2009 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 22, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 22, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 15, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 9, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 2, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 24, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 19, 2007 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 4, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 28, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 28, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 8, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 8, 2007 | ALIE | ASSIGNED TO LIE | — |
| Apr 18, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 18, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 17, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2006 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 20, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 27, 2006 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 24, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 23, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 10, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 16, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 16, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 16, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 15, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 26, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |